Shares of Nio (NIO) are edging higher as investors ignore recent Chinese mishaps and continue to push the price higher. Nio gained 1.86 percent on Thursday, closing at $42.62, above the important $42.00 mark. The Chinese Hang Seng tech index…
We have been covering Saddle Ranch Media (SRMX) in May, and in August it will be time for the company to release its quarterly earnings report 3 month ended June, 2023. This earnings report will have a bigger picture as…
I believe Atea Pharmaceutical (AVIR) to be the most under-rated COVID-19 related biotech stock in the market to date. Their interim analysis data relating to treatment of COVID-19 is unmatched in the field. With delta wave surging, many countries way…
Starting with the obvious – NKLA is a fraud and is absolutely nothing more than a smoke and mirrors show. Let’s take a look at the indictment on Trevor Milton: ” 1) Federal prosecutors accused Milton, who resigned as chairman…
Popular brokerage Robinhood (HOOD) is slated to open today on its first day of IPO trading. HOOD shares has been priced at $38 valuing the company at $32 billion to the previous $11 billion valuation in private markets. In addition,…
Senseonics (SENS), the continuous glucose monitoring company has been granted a new patent for their CGM device. The patent was granted yesterday July 27 and details that the device could be used for measuring and monitoring other medical analyte concentrations.…
On Monday July 26th Churchill Capital Corp. IV took the luxury electric vehicle maker Lucid Motors public. After the first day of trading is it worth buying Lucid Motors? In February, Churchill Capital IV (CCIV) a special-purpose acquisition company announced…
Oragenics (OGEN) is currently developing a next generation COVID vaccine, focused on the creation of the TerraCoV2 immunization product candidate, getting closer toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains…
Biotech company Tyme Technologies (TYME), who develops cancer metabolism-based therapies announced that it was granted a U.S. Patent for its metabolomic technology platform. The patent, U.S. Patent No. 11,058,638, involves a targeted delivery of therapeutics to cancer cells. Tyme has…
Noninvasive biological response medical device maker NanoVibronix (NAOV) jumped more than 30% in premarket trading Monday. The company announced a positive report concerning its device for urinary tract infections and was also featured in an article the Journal of Medical…
